on Viromed Medical AG (isin : DE000A3MQR65)
Viromed Engages in Cooperation Talks for Wound Care Innovation
Viromed Medical AG has confirmed rumors regarding discussions with a global MedTech company. The focus is a potential cooperation in the realm of wound care. Viromed aims to leverage its cold plasma medical device, ViroCAP®/OEM, to enhance wound healing.
The confirmation follows market speculation about this strategic alliance. The discussions are reportedly in advanced stages, although no final agreement has been reached yet.
Viromed Medical AG has assured its shareholders of timely updates adhering to legal obligations. The company emphasizes the potential of the ViroCAP® device in supporting wound treatment.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Viromed Medical AG news